Management of immunosuppression in the treatment of chronic lymphocytic leukemia

Auberger, J; Greil, R memo – Magazine of European Medical Oncology, 2013/1. 2013.

Systemische Therapie des prämenopausalen Mammakarzinoms

Ressler, S; Greil, R; Die Punkte. 2013.

Sequential chemoimmunotherapy of fludarabine, mitoxantrone, and cyclophosphamide induction followed by alemtuzumab consolidation is effective in T-cell prolymphocytic leukemia.

Hopfinger, G; Busch, R; Pflug, N; Weit, N; Westermann, A; Fink, AM; Cramer, P; Reinart, N; Winkler, D; Fingerle-Rowson, G; Stilgenbauer, S; Döhner, H; Kandler, G; Eichhorst, B; Hallek, M; Herling, M; Cancer. 2013; 119(12):2258-2267

What is causing my arthritis, doctor? A glimpse beyond the usual suspects in the pathogenesis of rheumatoid arthritis.

Pieringer, H; Studnicka-Benke, A; QJM. 2013; 106(3):219-228

Efficacy of tamoxifen ± aminoglutethimide in normal weight and overweight postmenopausal patients with hormone receptor-positive breast cancer: an analysis of 1509 patients of the ABCSG-06 trial.

Pfeiler, G; Stöger, H; Dubsky, P; Mlineritsch, B; Singer, C; Balic, M; Fitzal, F; Moik, M; Kwasny, W; Selim, U; Renner, K; Ploner, F; Steger, GG; Seifert, M; Hofbauer, F; Sandbichler, P; Samonigg, H; Jakesz, R; Greil, R; Fesl, C; Gnant, M; Br J Cancer. 2013; 108(7):1408-1414

Are the new breast cancer subtypes (luminal A, B etc.) of practical impact? No

Gampenrieder, SP DEUT MED WOCHENSCHR. 2013; 138(41): 2097-2097.

[Reply].

Psenak, O; Z Rheumatol. 2013; 72(2):190

Everolimus in Postmenopausal, Hormone Receptor-Positive Advanced Breast Cancer: Summary and Results of an Austrian Expert Panel Discussion

Gnant, M; Greil, R; Hubalek, M; Steger, G BREAST CARE. 2013; 8(4): 293-299.

Using cyclophosphamide in inflammatory rheumatic diseases.

Brummaier, T; Pohanka, E; Studnicka-Benke, A; Pieringer, H; Eur J Intern Med. 2013; 24(7):590-596

Prediction of poor outcome in CLL patients following first-line treatment with fludarabine, cyclophosphamide and rituximab.

Fink, AM; Böttcher, S; Ritgen, M; Fischer, K; Pflug, N; Eichhorst, B; Wendtner, CM; Winkler, D; Bühler, A; Zenz, T; Staib, P; Mayer, J; Hensel, M; Hopfinger, G; Wenger, M; Fingerle-Rowson, G; Döhner, H; Kneba, M; Stilgenbauer, S; Busch, R; Hallek, M; Leukemia. 2013; 27(9): 1949-1952.